GENOLUTION INC.

Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.

225220 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강서구 마곡중앙8로3길 63 (주)제놀루션, 강서구
Website:: https://genolution.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 2006, Genolution Inc. is a biotechnology company specializing in molecular diagnostics and RNA interference (RNAi) technologies. The company develops and manufactures comprehensive solutions for nucleic acid extraction, including automated instruments, reagents, and consumables. These systems serve high-throughput applications in molecular diagnostics (MDx), genetic testing, and life sciences research. In its RNAi division, Genolution provides products like siRNA and shRNA and offers dsRNA synthesis services for gene expression studies. The company leverages its expertise to develop innovative products, including RNAi-based therapies for applications in fields such as agrigenomics.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for GENOLUTION INC. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all GENOLUTION INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GENOLUTION INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
KANABO GROUP PLC Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.	United Kingdom	KNB
Kancera Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.	Sweden	KAN
KANGSTEM BIOTECH CO., LTD. Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.	South Korea	217730
Karo Pharma AB Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.	Sweden	KARO
KBIO COMPANY Inc. Using a plant-based platform to rapidly develop biologics for public health.	South Korea	038530
Keeps Biopharma Inc. Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.	South Korea	256940
Kidswell Bio Corporation Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.	Japan	4584
Kinarus Therapeutics Holding AG A specialty pharma firm developing and selling medicines for rare and specialty diseases.	Switzerland	KNRS
KISSEI PHARMACEUTICAL CO.,LTD. Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.	Japan	4547
Klaria Pharma Holding AB Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.	Sweden	KLAR